Patrick Soon-Shiong, M.D.

Patrick Soon-Shiong, M.D.

Global Chief Scientific and Medical OfficeratImmunityBio· In proxies 2022–2025

Pay in FY2025+50% from the year before · ImmunityBio stock -22.7% the same year

Patrick Soon-Shiong, M.D. was paid $12.3M in FY2025 (Dec), up 50%. ImmunityBio stock fell 22.7% that year.

Pay$100 in the stock at the end of FY21 → $33
Pay is from the Summary Compensation Table of each ImmunityBio proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. ImmunityBioPublic company · 4 yr
    • Global Chief Scientific and Medical Officer2022 – Present · 4 yrStock in role +32%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?